(Adds details throughout) July 10 (Reuters) – The U.S. Food and Drug Administration said on Friday it has approved a wearable form of Sanofi's blood cancer drug, Sarclisa, offering multiple myeloma
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)